FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to crystalline form of maleate 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyano-phenyl)urea, which has X-ray powder diffraction pattern including peaks at 2θ: 11.6, 12.1 and 19.6 °2θ ± 0.2 °2θ. Also described is a pharmaceutical composition based on the crystalline form of said urea maleate.
EFFECT: technical result is obtaining urea maleate, which has improved chemical and thermal stability during storage, low hygroscopicity while maintaining chemical and enantiomeric stability.
12 cl, 7 ex, 8 tbl, 5 dwg
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)BENZOXAZOLE | 2015 |
|
RU2692252C2 |
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE | 2011 |
|
RU2570198C2 |
CRYSTALLINE FORM OF 6-[(4R)-4-METHYL-1,1-DIOXIDO-1,2,6-THIADIAZINAN-2-YL]ISOQUINOLINE-1-CARBONITRILE | 2015 |
|
RU2698194C2 |
PENTACYCLIC COMPOUND SALT AND CRYSTAL THEREOF | 2020 |
|
RU2820938C2 |
CRYSTALLINE MODIFICATIONS OF 3-(1H-INDOL-3-YL)-4-(4-METHYLPIPERAZIN-1-YL)QUINAZOLIN-4-YL)PYRROL-2,5-DIONE | 2007 |
|
RU2481341C2 |
CRYSTALLINE FORMS OF 6-(1H-IMIDAZOL-1-YL)-2-PHENYLQUINAZOLINE AND ITS SALTS | 2010 |
|
RU2557547C2 |
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE, SUITABLE FOR TREATMENT OF ABNORMAL GROWTH OF CELLS IN MAMMALS | 2008 |
|
RU2518898C2 |
SALTS OF 1-(4-(2-((1-(3,4-DIFLUOROPHENYL)-1N-PYRAZOL-3-YL)METHOXY)ETHYL)PIPERAZIN-1-YL)ETHANONE | 2016 |
|
RU2727974C2 |
CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS | 2010 |
|
RU2572848C2 |
STABLE FORMULATIONS OF IMANITIB | 2008 |
|
RU2470641C2 |
Authors
Dates
2020-03-24—Published
2016-04-13—Filed